1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,610 | 0,620 | 09:02 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.12.25 | Bioretec Ltd's schedule for financial reporting and Annual General Meeting in 2026 | 258 | PR Newswire | Bioretec Ltd Company announcement 22 December 2025 at 5:30 p.m. EETTAMPERE, Finland, Dec. 22, 2025 /PRNewswire/ -- In 2025, Bioretec will publish the following financial reports:
financial... ► Artikel lesen | |
| 16.12.25 | Bioretec Board Approves Updated Strategy, Financial Targets For 2026-2028 Period | 5 | RTTNews | ||
| 16.12.25 | Inside information: Bioretec updates its strategy for 2026-2028 and provides new financial targets | 144 | PR Newswire | Bioretec Ltd Inside information 16 December 2025 at 8:45 a.m. EETTAMPERE, Finland, Dec. 16, 2025 /PRNewswire/ -- As announced in September, Bioretec Ltd ("Bioretec" or the "Company") has... ► Artikel lesen | |
| BIORETEC Aktie jetzt für 0€ handeln | |||||
| 15.12.25 | Bioretec Secures FDA Breakthrough Device Designation For RemeOs DrillPin | 5 | RTTNews | ||
| 14.12.25 | Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs DrillPin | 471 | PR Newswire | Bioretec Ltd Inside information 14 December 2025 at 5:45 p.m. EETTAMPERE, Finland, Dec. 14, 2025 /PRNewswire/ -- Bioretec Oy ("Bioretec" or the "Company"), a pioneer in biodegradable orthopedic... ► Artikel lesen | |
| 04.12.25 | Change negotiations completed at Bioretec | 284 | PR Newswire | Bioretec Ltd Press release 4 December 2025 at 12.00 p.m. EETTAMPERE, Finland, Dec. 4, 2025 /PRNewswire/ -- On November 12, 2025, Bioretec announced the start of statutory change negotiations... ► Artikel lesen | |
| 13.11.25 | Bioretec Oy Q3 Loss Widens | 1 | RTTNews | ||
| 13.11.25 | Bioretec Ltd's business review January-September 2025: Strengthening commercial foundations and strategy design | 504 | PR Newswire | Bioretec Ltd Company release 13 November 2025 at 8.30 a.m. EET
TAMPERE, Finland, Nov. 13, 2025 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for... ► Artikel lesen | |
| 12.11.25 | Inside information: Bioretec initiates change negotiations to enhance operational efficiency and competitiveness | 271 | PR Newswire | Bioretec Ltd Inside information 12 November 2025 at 12.30 p.m. EET
TAMPERE, Finland, Nov. 12, 2025 /PRNewswire/ -- Bioretec Ltd is initiating change negotiations in accordance... ► Artikel lesen | |
| 31.10.25 | Bioretec Ltd.: Half-year report 2025 - Correction | 486 | PR Newswire | Bioretec Ltd Company release 31 October 2025 at 8.30 a.m. EET
TAMPERE, Finland, Oct. 31, 2025 /PRNewswire/ -- Bioretec announced on 27 October 2025 that it will adjust and restate... ► Artikel lesen | |
| 27.10.25 | Inside information: Bioretec adjusts and restates previously reported net sales FOR H1/2025 and does not expect accelerated sales in 2025 | 309 | PR Newswire | Bioretec Ltd Inside information 27 October 2025 at 9.14 p.m. EEST
TAMPERE, Finland, Oct. 27, 2025 /PRNewswire/ -- On 22 November 2024, Bioretec Ltd ("Bioretec" or the "Company")... ► Artikel lesen | |
| 27.10.25 | Inside information: Bioretec is revising its financial targets, deems that the current financial targets will not be met and withdraws its financial targets | 283 | PR Newswire | Bioretec Ltd Inside information 26 October 2025 at 10.00 a.m. EEST
TAMPERE, Finland, Oct. 27, 2025 /PRNewswire/ -- On 12 September 2025, Bioretec Ltd ("Bioretec" or the "Company")... ► Artikel lesen | |
| 01.10.25 | Bioretec's RemeOs Screw LAG Solid Receives CMS Transitional Pass-Through Payment in the US | 250 | PR Newswire | TAMPERE, Finland, Oct. 1, 2025 /PRNewswire/ -- Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today that the Centers for Medicare & Medicaid Services (CMS) has granted... ► Artikel lesen | |
| 16.09.25 | Composition of Bioretec's Shareholders' Nomination Board | 3 | Cision News | ||
| 15.09.25 | Bioretec Oy: Inside information: Anne-Mari Matikainen appointed as Interim Chief Financial Officer of Bioretec; CFO Johanna Salko to depart before year-end | 175 | GlobeNewswire (Europe) | Bioretec Ltd Inside information 15 September 2025 at 5.30 p.m. EEST
Bioretec Ltd., a pioneer in absorbable orthopedic implants appoints Anne-Mari Matikainen as Interim Chief Financial Officer, effective... ► Artikel lesen | |
| 15.09.25 | New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register | 1 | Cision News | ||
| 15.09.25 | Bioretec Oy: Shares Subscribed With Option Rights | 189 | GlobeNewswire | NOTICE, SEPTEMBER 15, 2025 SHARES (Record Id 315934) A total of 5,000 shares will be traded as old shares as of September 16, 2025 on First North Growth Market Finland.
Identifiers of Bioretec Oy's... ► Artikel lesen | |
| 12.09.25 | Bioretec Oy: Inside information: Bioretec updates the commercialization status of RemeOs DrillPin | 302 | GlobeNewswire (Europe) | Bioretec Ltd Inside information 12 September 2025 at 11:00 a.m. EEST
Bioretec Ltd., a pioneer in absorbable orthopedic implants, announces an update to the commercialization status of the RemeOs DrillPin.... ► Artikel lesen | |
| 04.09.25 | Bioretec adds Harvard orthopedic surgeon to scientific board | 2 | Investing.com | ||
| 04.09.25 | Bioretec Appoints Dr. Christopher W. DiGiovanni to Scientific Advisory Board | 277 | PR Newswire | Bioretec Ltd Press Release 4 September 2025 at 3 p.m. EET
TAMPERE, Finland, Sept. 4, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in bioresorbable orthopedic implants, today announced... ► Artikel lesen |
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,720 | 0,00 % | Eckert & Ziegler - Kurzbericht zur Aktienentwicklung | ||
| DRAEGERWERK | 72,00 | 0,00 % | EQS-News: Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener Aktien - Abschlussmeldung | EQS-News: Drägerwerk AG & Co. KGaA
/ Schlagwort(e): Sonstiges
Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener... ► Artikel lesen | |
| INTUITIVE SURGICAL | 506,70 | -0,12 % | $100 Invested In Intuitive Surgical 20 Years Ago Would Be Worth This Much Today | ||
| INSULET | 251,00 | -0,36 % | Is it the Right Time to Add Insulet Stock to Your Portfolio? | ||
| CYTOSORBENTS | 0,587 | -0,17 % | Cytosorbents Corp: CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update | Third quarter 2025 revenue of $9.5 million, up 10% year-over-year
Amended credit agreement with Avenue Capital Group which strengthens our balance sheet... ► Artikel lesen | |
| GENEDX | 135,80 | +3,34 % | GeneDx Taps Dr. Linda Genen as Chief Medical Officer | ||
| REVENIO GROUP | 22,100 | +0,23 % | Revenio Group Corporation: Change in the Leadership Team: Robin Pulkkinen to leave his position | Revenio Group Corporation | Stock Exchange Release | December 18, 2025 at 08:30:00 EET
Revenio Group Corporation's Chief Financial Officer and member of the Leadership Team, Robin Pulkkinen, has resigned... ► Artikel lesen | |
| OPTOMED | 3,620 | 0,00 % | Optomed Oyj: Interim Report, January - September 2025 | Optomed PlcStock Exchange Release 6 November 2025 at 9.00, Helsinki
Optomed Plc: Interim Report, January - September 2025July- September 2025
Revenue increased by 42.1 percent to EUR 4.4 (3.1) million.
Currency-adjusted... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,100 | 0,00 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,300 | +1,33 % | Where Alignment Healthcare Stands With Analysts | ||
| FRESENIUS MEDICAL CARE | 40,220 | 0,00 % | Abend-Update: Fresenius Medical Care sorgt für Spannung - kommt bald die Entscheidung? | ||
| FRESENIUS | 48,440 | 0,00 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,340 | 0,00 % | Abend-Update: Carl Zeiss Meditec-Aktie auf Höhenflug - Anleger feiern starkes Comeback! | ||
| BRIGHTSPRING HEALTH SERVICES | 40,670 | +3,59 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PACS GROUP | 40,880 | 0,00 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |
BIORETEC OY gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,580 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIORETEC OY finden Sie auf Wallstreet Online.